[Therapy options for malignant eyelid tumors]

Area of Science:

• Ophthalmology
• Dermatology
• Oncology

Background:

• Basal cell carcinomas are the most frequent malignant eyelid tumors.
• Clinical diagnosis is often presumptive, requiring histopathological confirmation.
• Other eyelid malignancies include squamous cell carcinomas, sebaceous gland carcinomas, melanomas, and Merkel cell carcinomas.

Purpose of the Study:

• To outline the diagnostic and staging procedures for malignant eyelid tumors.
• To highlight the importance of histopathological confirmation.
• To discuss the role of imaging in staging and the emerging non-surgical treatment options.

Main Methods:

• Clinical evaluation including history, symptoms, signs, inspection, palpation, and slit-lamp examination.
• Histopathological examination for definitive diagnosis and tumor typing.
• Imaging techniques such as palpation, ultrasonography, computed tomography (CT) with contrast, and magnetic resonance imaging (MRI) for staging.
• Surgical excision with microscopic control is a primary treatment goal.

Main Results:

• Histopathological confirmation is essential for accurate diagnosis and classification of eyelid tumors.
• Metastasis of certain eyelid cancers (e.g., squamous cell carcinoma) can occur via lymphatics to regional lymph nodes.
• Imaging modalities are crucial for TNM staging, especially in cases of perineural invasion.

Conclusions:

• Accurate diagnosis of eyelid tumors relies on a combination of clinical assessment and histopathology.
• Comprehensive staging, utilizing imaging, is vital for effective management of malignant eyelid tumors.
• Non-surgical treatment modalities are increasingly important in the management of these conditions.